Get the Stockscreener App
4.9223
6.60%
-0.3777
Neonc Technologies Holdings Inc stock is traded at $4.9223, with a volume of 18,524.
It is down -6.60% in the last 24 hours and down -33.91% over the past month.
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").
See More
Previous Close:
$5.30
Open:
$5.33
24h Volume:
18,524
Relative Volume:
0.32
Market Cap:
$131.67M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-25.11%
1M Performance:
-33.91%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$4.68
$5.641
1-Week Range:
$4.68
$6.875
52-Week Range:
$4.1101
$21.00
Neonc Technologies Holdings Inc Stock (NTHI) Company Profile
Name
Neonc Technologies Holdings Inc
Sector
Industry
Phone
310 663 7831
Address
23975 PARK SORRENTO, CALABASAS
Compare NTHI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTHI
Neonc Technologies Holdings Inc
|
4.9223 | 131.67M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.92 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
514.76 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
315.55 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
544.26 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
256.40 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Neonc Technologies Holdings Inc Stock (NTHI) Latest News
NeOnc Technologies Appoints Dr. Josh Neman as CCO - TipRanks
NeOnc Technologies files to sell 10.02M shares of common stock by selling shareholders - MSN
NeOnc Technologies Files Prospectus for Resale of Shares - marketscreener.com
NeOnc Technologies appoints new chief clinical officer By Investing.com - Investing.com Nigeria
NeOnc Technologies Appoints New Chief Clinical Officer - TipRanks
NeOnc Technologies Holdings Appoints Dr. Josh Neman as Chief Clinical Officer - citybiz
NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs - The Manila Times
NeOnc Technologies Appoints Dr. Josh Neman as Chief Clinical Officer to Enhance Brain Tumor Treatment and Accelerate Clinical Trials - Nasdaq
NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman - GlobeNewswire
NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance ... - Bluefield Daily Telegraph
Neonc technologies CFO Garnett Keithly sells $164,425 in stock By Investing.com - Investing.com South Africa
Neonc technologies CFO Garnett Keithly sells $164,425 in stock - Investing.com India
'New Frontiers' Presents 4 Companies Revolutionizing: Brian CancNORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
"New Frontiers" Presents Featuring Athena Clinic, MonDak Portables, LLC, NeOnc Technologies Holdings, Inc. & Hollobus Technologies. The content in the episode is a Planet TV Studios Original & it is brought to you by & sponsored by Planet TV Studios. - Kalkine Media
Neonc technologies CFO Garnett Keithly acquires $976 in shares By Investing.com - Investing.com South Africa
Neonc technologies CFO Garnett Keithly acquires $976 in shares - Investing.com Australia
Major Stock Acquisition by NeOnc Technologies’ President! - TipRanks
NeOnc Technologies Appoints New President Amid Strategic Moves - MSN
Clinical Trial of NEO100 Recruiting Patients With Malignant Gliomas - Curetoday
NeOnc Technologies announces global patent portfolio totals 176 - TipRanks
NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets - The Manila Times
NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical - Bluefield Daily Telegraph
NeOnc Sees Share Price Fall Since Going Public - Los Angeles Business Journal
NeOnc Technologies expects full enrollment in Phase 2a trial of NEO100-01 - TipRanks
NeOnc Technologies Expects Full Enrollment in Phase 2a Trialfor NEO100-01 by September - marketscreener.com
Neonc Technologies Holdings Expects Full Enrollment In Promising Phase 2A Trial Of Neo100-01 For Malignant Gliomas In September - MarketScreener
NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September - The Manila Times
Planet TV Studios Airing “New Frontiers” Episode on NeOnc Technologies Holdings, Inc. – Saturday, April 26th, - EIN News
New CEOs at Alterome, Valo and Imbria - BioCentury
NeOnc Technologies Appoints Executive Chairman Amir Heshmatpour as President - MarketScreener
NeOnc Technologies Holdings, Inc. Executive Chairman, Amir - GlobeNewswire
Germany's economy is expected to stagnate at best this year - The Globe and Mail
2 Reasons Nu Holdings Stock Is a Buy Before May 13 - The Globe and Mail
Rigetti Computing Stock (RGTI) Surges 21% as Market Optimism Returns - The Globe and Mail
NeOnc Technologies Phase 1 Trial Enrollment for NEO212 Brain Cancer Drug Nears Full Enrollment - MarketScreener
NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy - GlobeNewswire
Dow Jones Index Daily Report: DIA Rebounds Today After Tariff Tantrum - The Globe and Mail
Nvidia Stock (NVDA) Smashes Back as AI Demand Counters Tariff Panic - The Globe and Mail
NeOnc Technologies Partners with CBCC for Clinical Expansion - TipRanks
Neonc Technologies appoints new accounting firm By Investing.com - Investing.com Canada
Neonc Technologies appoints new accounting firm - Investing.com India
NeOnc Technologies receives RPDD for NEO100 - TipRanks
NeOnc Technologies Holdings: New IPO gets a Rare Pediatric Disease Designation and a 37.92% Jump in the Market - RagingBull
NeOnc Technologies Holdings' Perillyl Alcohol Receives FDA's Rare Pediatric Disease Designation - MarketScreener
NeOnc Falls Despite FDA Nod - Baystreet.ca
NeOnc Technologies Holdings, Inc. Receives Rare Pediatric - GlobeNewswire
Robinhood, Couchbase And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas - Yahoo Finance
Neonc Technologies Holdings Inc Stock (NTHI) Financials Data
There is no financial data for Neonc Technologies Holdings Inc (NTHI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Neonc Technologies Holdings Inc Stock (NTHI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| CHEN THOMAS C | CEO |
May 21 '25 |
Buy |
7.25 |
2,759 |
20,002 |
548,959 |
| CHEN THOMAS C | CEO |
May 22 '25 |
Buy |
7.38 |
2,709 |
20,000 |
551,668 |
| GARNETT KEITHLY | CFO |
May 22 '25 |
Buy |
7.29 |
675 |
4,921 |
240,900 |
| GARNETT KEITHLY | CFO |
May 19 '25 |
Buy |
7.23 |
135 |
976 |
240,225 |
| Delshad Jim | Director |
May 12 '25 |
Buy |
7.22 |
5,000 |
36,110 |
55,310 |
| Delshad Jim | Director |
Mar 26 '25 |
Buy |
16.05 |
50 |
802 |
50,260 |
| Delshad Jim | Director |
Apr 17 '25 |
Buy |
6.92 |
50 |
346 |
50,310 |
| CHEN THOMAS C | CEO |
May 12 '25 |
Buy |
7.00 |
400 |
2,800 |
546,200 |
| Heshmatpour Amir F | President |
May 16 '25 |
Buy |
16.87 |
3,510 |
59,221 |
1,760,000 |
| Heshmatpour Amir F | President |
May 11 '25 |
Buy |
7.51 |
1,600 |
12,016 |
1,751,600 |
1.59%
0.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):